EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation

Guijiang Sun, Yi Shao, Qianwang Ma, Shengju Song, Yutong Chen, Yang Li, Yue Gao, Haitao Wang, Zhiqun Shang

Discover Oncology · 05.10.2024 · 15 (1)

DOI: 10.1007/s12672-024-01392-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 05.10.2024. Verfasst von Guijiang Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Disease and Blood Purification, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Institute of Urology Talent Support Program, Tianjin Municipal Education Commission Research Plan Project (Natural Sciences).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research investigates the intricate involvement of nuclear Transcription Factor Y Subunit Alpha (NFYA) in the advancement of castration-resistant prostate cancer (CRPC) and its consequential impact on early Growth Response 4 (EGR4) expression. NFYA demonstrates a significant elevation in CRPC tissues and cell lines, displaying robust upregulation in metastatic prostate cancer (mPCa) samples, closely associated with the Gleason score. Immunohistochemistry validates heightened nuclear staining of NFYA in CRPC patients, highlighting its crucial role in the progression of advanced prostate cancer. Silencing NFYA through siRNA in androgen-independent cell lines markedly impedes cell growth and migration, emphasizing NFYA's pivotal role in promoting CRPC behavior. RNA-seq analysis identifies EGR4 as a downstream target of NFYA, with both genes consistently upregulated in CRPC. Validating this finding, heightened expression of EGR4 is observed in CRPC samples. In vivo studies utilizing a mouse model demonstrate that NFYA silencing substantially inhibits LNCaP-AI/22RV1shNFYA xenograft tumor growth, accompanied by reduced expression of EGR4 and Ki67. This comprehensive study reveals the multifaceted role of NFYA in CRPC progression, elucidates its downstream impact on EGR4, and underscores the therapeutic potential of targeting NFYA to inhibit CRPC growth in vivo. These findings contribute valuable insights into potential therapeutic strategies for managing CRPC.

Schlagwörter

Stichwörter der Autor:innen

Castration resistant prostate cancerEGR4NFYAProgression

Autor:innen und Institutionen

  • Department of Kidney Disease and Blood Purification, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Department of Urology, Tianjin Institute of Urology, The second hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Department of Oncology, Tianjin Institute of Urology, The second hospital of Tianjin Medical University, Tianjin, 300211, China. peterrock2000@126.com.
  • Department of Kidney Disease and Blood Purification, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China. zhiqun_shang@tmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Tianjin Institute of Urology Talent Support Program
  • Tianjin Municipal Education Commission Research Plan Project (Natural Sciences)
  • Tianjin Science and Technology Commissioner Project
  • Tianjin Hospital Association Project

Zitieren

APA

Sun, G., Shao, Y., Ma, Q., Song, S., Chen, Y., Li, Y., Gao, Y., Wang, H., & Shang, Z. (2024). NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01392-4

Vancouver

Sun G, Shao Y, Ma Q, Song S, Chen Y, Li Y, et al. NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01392-4

BibTeX
@article{Sun2024,
  author = {Sun, Guijiang and Shao, Yi and Ma, Qianwang and Song, Shengju and Chen, Yutong and Li, Yang and Gao, Yue and Wang, Haitao and Shang, Zhiqun},
  title = {NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation},
  journal = {Discover Oncology},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1007/s12672-024-01392-4}
}
Kostenlos starten →